BUZZ-Aeterna Zentaris Inc: To open at record low after FDA rejection

Thu Nov 6, 2014 8:16am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian company's U.S.-listed shares set to open down 53 pct at a record low of 59 cents

** Says U.S. Food and Drug Administration rejected its experimental growth hormone diagnostic test

** FDA asks Aeterna to conduct a new trial to demonstrate the effectiveness of macimorelin, the company's experimental test designed to determine if adults' pituitary glands are secreting enough growth hormone

** Up to Wednesday's close, stock had fallen 7 pct this year